whitepaper
Retaining the ?Sunshine? in pharmaceutical meetings and events ? A look at dealing with the Sunshine Act in USA
by
Rajeswari Venkatesh
30 June 2014
The Physician Payment Sunshine Act ? Section 6002 of the Patient Protection and Affordable Care Act (PPACA) is the most recent regulation in USA which is impacting the pharmaceutical and medical device industry. It involves reporting of the transfer of value (either in cash or kind) to health care professionals (HCPs) and teaching hospitals from pharmaceutical companies and medical device companies.
Leave a comment
Related Insights:
View AllGet more stories like this
Subscirbe for more news,updates and insights from Beroe